Cruciani G - Search Results

1

Interaction of DDSDEEN peptide with N-CAM protein. Possible mechanism enhancing neuronal differentiation.

Marsili V, Lupidi G, Berellini G, Calzuola I, Perni S, Cruciani G, Gianfranceschi GL. Marsili V, et al. Among authors: cruciani g. Peptides. 2008 Dec;29(12):2232-42. doi: 10.1016/j.peptides.2008.09.008. Epub 2008 Sep 21. Peptides. 2008. PMID: 18852000

2

Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists.

Berellini G, Cruciani G, Mannhold R. Berellini G, et al. Among authors: cruciani g. J Med Chem. 2005 Jun 30;48(13):4389-99. doi: 10.1021/jm049024x. J Med Chem. 2005. PMID: 15974591

3

Predicting protein pK(a) by environment similarity.

Milletti F, Storchi L, Cruciani G. Milletti F, et al. Among authors: cruciani g. Proteins. 2009 Aug 1;76(2):484-95. doi: 10.1002/prot.22363. Proteins. 2009. PMID: 19241472

4

Targeting the conformational transitions of MDM2 and MDMX: insights into dissimilarities and similarities of p53 recognition.

Macchiarulo A, Giacchè N, Carotti A, Baroni M, Cruciani G, Pellicciari R. Macchiarulo A, et al. Among authors: cruciani g. J Chem Inf Model. 2008 Oct;48(10):1999-2009. doi: 10.1021/ci800146m. Epub 2008 Oct 1. J Chem Inf Model. 2008. PMID: 18826207

5

A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields.

Broccatelli F, Carosati E, Neri A, Frosini M, Goracci L, Oprea TI, Cruciani G. Broccatelli F, et al. Among authors: cruciani g. J Med Chem. 2011 Mar 24;54(6):1740-51. doi: 10.1021/jm101421d. Epub 2011 Feb 22. J Med Chem. 2011. PMID: 21341745 Free PMC article.

6

Interaction of Mycotoxin Alternariol with Serum Albumin.

Fliszár-Nyúl E, Lemli B, Kunsági-Máté S, Dellafiora L, Dall'Asta C, Cruciani G, Pethő G, Poór M. Fliszár-Nyúl E, et al. Among authors: cruciani g. Int J Mol Sci. 2019 May 12;20(9):2352. doi: 10.3390/ijms20092352. Int J Mol Sci. 2019. PMID: 31083629 Free PMC article.

7

Getting Insights into Structural and Energetic Properties of Reciprocal Peptide-Protein Interactions.

Trisciuzzi D, Siragusa L, Baroni M, Autiero I, Nicolotti O, Cruciani G. Trisciuzzi D, et al. Among authors: cruciani g. J Chem Inf Model. 2022 Feb 28;62(4):1113-1125. doi: 10.1021/acs.jcim.1c01343. Epub 2022 Feb 11. J Chem Inf Model. 2022. PMID: 35148095

8

GRIND/ALMOND investigations on CysLT1 receptor antagonists of the quinolinyl(bridged)aryl type.

Benedetti P, Mannhold R, Cruciani G, Ottaviani G. Benedetti P, et al. Among authors: cruciani g. Bioorg Med Chem. 2004 Jul 1;12(13):3607-17. doi: 10.1016/j.bmc.2004.04.018. Bioorg Med Chem. 2004. PMID: 15186845

9

Homodimeric enzymes as drug targets.

Cardinale D, Salo-Ahen OM, Ferrari S, Ponterini G, Cruciani G, Carosati E, Tochowicz AM, Mangani S, Wade RC, Costi MP. Cardinale D, et al. Among authors: cruciani g. Curr Med Chem. 2010;17(9):826-46. doi: 10.2174/092986710790712156. Curr Med Chem. 2010. PMID: 20156173 Review.

10

A novel strategy for improving ligand selectivity in receptor-based drug design.

Pastor M, Cruciani G. Pastor M, et al. Among authors: cruciani g. J Med Chem. 1995 Nov 10;38(23):4637-47. doi: 10.1021/jm00023a003. J Med Chem. 1995. PMID: 7473591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

348 results

Search Page

Filters